Ascenion GmbH is a German-based technology transfer company founded in 2001. The enterprise is dedicated to bringing innovative life sciences research from European public institutions to the market. Ascenion evaluates around 100 invention disclosures per year and handles approximately 60 patent applications and licensing agreements with industry. The company also provides support and guidance to new spin-offs, holding equity in more than 30 of these ventures. Their efforts have resulted in the founding of several new companies and the transformation of creative medical approaches into approved drugs, positively impacting thousands of patients. With a focus on biotechnology, healthcare, and manufacturing sectors, Ascenion stands at the intersection of cutting-edge research and successful commercialization.
There is no investment information
No recent news or press coverage available for Ascenion GmbH.